|
|
|
Corporate Profile: Acura
Pharmaceuticals
| Summary: |
| The
focus of Acura Pharmaceuticals is the research and
development of proprietary formulation technologies
intended to deter the abuse of orally administered
opioid analgesic products. |
| Address (HQ): |
616 N. North Court
Suite 120
Palatine, IL 60067 |
16235 SR-17
Culver, IN 46511 |
| Phone #'s (HQ): |
| Main |
(847) 705-7709 |
(574) 842-3305 |
| Human
Resources |
not known |
not known |
| Investor
Relations |
(847) 705-7709 |
not known |
| Fax #'s (HQ): |
| Main |
(847) 705-5399 |
(574) 842-2519 |
| Human
Resources |
not known |
not known |
| Investor
Relations |
not known |
not known |
| Financial
information: |
| ACUR |
| Internet
job postings: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
